JDM Financial Group’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Other funds holding CATX
JDM Financial Group's CATX Position: Q3 2026 in Review
JDM Financial Group held its Perspective Therapeutics (CATX) position steady in Q3 2026 at 3,500 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #212.
JDM Financial Group first reported a position in CATX in Q4 2022 and has held it in 16 quarters since. The position peaked at $46.7K in Q3 2024. 120 funds tracked by Wall St. Rank hold CATX as of Q3 2026.
- JDM Financial Group held 3,500 shares of Perspective Therapeutics worth $9.6K as of Q3 2026.
- JDM Financial Group left its Perspective Therapeutics share count unchanged in Q3 2026.
- Perspective Therapeutics made up ﹤0.01% of JDM Financial Group's portfolio in Q3 2026, its #212 holding.
- JDM Financial Group first reported a position in Perspective Therapeutics in Q4 2022 and has held it in 16 quarters since.
- JDM Financial Group's Perspective Therapeutics position peaked at $46.7K in Q3 2024.
- 120 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.
Based on JDM Financial Group's 13F filing for Q3 2026, filed 17 Nov 2026.